New GLP-1 Weight Loss Pill Approved: What This Means for You in London
A major breakthrough in weight loss treatment has just been announced.
Eli Lilly has introduced a new oral GLP-1 medication, Orforglipron (FoundaYO™)—the first of its kind in pill form.
This is big news for patients who want an alternative to injections like Mounjaro or Ozempic.
But before you consider any GLP-1 medication, there is one critical step most people skip.
You must test your body first.
What Is the New GLP-1 Pill?
The newly approved oral GLP-1 drug works by:
- Reducing appetite
- Slowing digestion
- Improving blood sugar control
Unlike injections, this pill offers:
- Easier daily use
- Greater accessibility
- Wider adoption potential
This could change the entire weight loss market in 2026.
Why This Is Great News (But Not for Everyone)
This breakthrough is exciting.
However, GLP-1 medications are not risk-free.
They directly affect:
- Hormones
- Metabolism
- Liver function
- Pancreatic activity
Taking them without testing is a mistake.
The Biggest Mistake People Make Before GLP-1 Treatment
Most people:
- Start medication based on weight alone
- Skip baseline blood testing
- Ignore underlying health issues
This can lead to:
- Side effects
- Poor results
- Hidden complications
Your body needs to be assessed first.
Get Tested Before Starting Any GLP-1 Medication
At Marylebone Diagnostic Centre, we strongly recommend pre-treatment blood testing.
This ensures:
- You are medically suitable
- Risks are identified early
- Your results are optimised
Recommended “Pre-GLP-1” Blood Tests
1. Full Metabolic Profile
Checks:
- Blood sugar (HbA1c)
- Insulin resistance
- Kidney function
- Electrolytes
Book Now
2. Liver Function Test (LFT)
GLP-1 drugs impact the liver.
This test assesses:
- ALT, AST
- Bilirubin
- Liver stress
3. Thyroid & Hormone Panel
Hormones affect weight and metabolism.
We check:
- TSH
- Free T3 / T4
- Cortisol
4. Lipid & Cardiovascular Profile
Important for heart health risk.
Includes:
- Cholesterol
- Triglycerides
- HDL / LDL
Why Testing Before GLP-1 Is Critical
Without testing, you may:
- Miss underlying thyroid issues
- Ignore liver strain
- Overlook insulin resistance
- Start treatment that is not suitable
GLP-1 drugs are powerful – but they must be used correctly.
MDC Approach: Safety First, Results Second
At Marylebone Diagnostic Centre, we focus on:
- Safety before prescription
- Data-driven decisions
- Personalised health insights
This is the difference between:
- Guesswork
- And clinical precision
Should You Consider the New GLP-1 Pill?
It may be suitable if:
- You struggle with weight management
- Lifestyle changes have not worked
- You meet clinical criteria
But never start without proper testing.
Final Message: Do Not Follow Trends – Follow Data
The new GLP-1 pill is a breakthrough.
But your health is individual.
Before taking any weight loss medication in 2026:
✔ Get tested
✔ Understand your body
✔ Make informed decisions
Start safely with a full assessment.
Book Now: marylebonediagnosticcentre.com
📞 +44 7495 970109
📍 73 Baker Street, London W1U 6RD
🚶 5-minute walk from Baker Street tube
Results within 24 – 42 hours. No GP referral needed.
It is an oral medication that mimics GLP-1 hormones to help with weight loss and blood sugar control.
It offers convenience, but safety still depends on your individual health and medical profile.
Yes. Blood tests help ensure the treatment is safe and suitable for you.
This is not recommended. Proper testing reduces risks and improves results.
Written By
Dr Lauren
Consultant in Women’s Health & Fertility Specialist
Contributor to clinical education at Marylebone Diagnostic Centre
